STN1012600 ophthalmic solution 0.002%

DRUG3 trials

Sponsors

Santen Pharmaceutical Co., Ltd.

Conditions

Healthy Adult Males VolunteersOpen Angle Glaucoma, Ocular HypertensionPrimary Open Angle Glaucoma, Ocular Hypertension

Phase 1

Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers

CompletedNCT05905653

Santen Pharmaceutical Co., Ltd.Healthy Adult Males Volunteers

Start: 2023-05-25End: 2023-06-21Updated: 2023-12-05

Phase 3

A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

CompletedNCT05495061

Santen Pharmaceutical Co., Ltd.Primary Open Angle Glaucoma, Ocular Hypertension

Start: 2022-08-09End: 2023-04-18Updated: 2023-12-05

A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension

CompletedNCT05503901

Santen Pharmaceutical Co., Ltd.Open Angle Glaucoma, Ocular Hypertension

Start: 2022-08-08End: 2024-01-30Updated: 2024-07-15